产品详情
In vitro | DMSO | Warmed: 53 mg/mL (185.17 mM) | |
Water | Insoluble | ||
Ethanol | 3 mg/mL (10.48 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 34.94 mL | 174.7 mL | 349.41 mL |
0.5 mM | 6.99 mL | 34.94 mL | 69.88 mL |
1 mM | 3.49 mL | 17.47 mL | 34.94 mL |
5 mM | 0.7 mL | 3.49 mL | 6.99 mL |
*The above data is based on the productmolecular weight 286.2 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10495 |
---|---|
作用机制 | Inhibitor (抑制剂), Agonist (激动剂) |
M. Wt | 286.2 |
Formula | C15H10O6 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 520-18-3 |
SMILES | C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O |
产品标签
Product Questions
Product Questions
Telatinib (BAY 57-9352)
Telatinib (BAY 57-9352)是一种口服的血管内皮生长因子受体2和3(VEGFR2/3)和血小板衍生的生长因子受体β酪氨酸…
Tivozanib (AV-951)
Tivozanib (AV-951)是一种口服VEGF受体酪氨酸激酶抑制剂,旨在抑制所有三种VEGF受体。
TPT-260 (Dihydrochloride)
TPT-260是噻吩硫脲衍生物。
E-7050 (Golvatinib)
E-7050 (Golvatinib)是具有潜在抗肿瘤活性的c-Met(肝细胞生长因子受体)和VEGFR-2(血管内皮生长因子受体-2)酪氨酸…
Cediranib (AZD2171)
Cediranib (AZD2171)是一种高效的VEGFR(KDR)抑制剂,此外对c-Kit和PDGFRβ也具有相似的抑制活性,对VEGFR的选择性比P…